Chapter 4 - The Capsule
Surgery lasted forty minutes.
Melissa Hart removed the capsule through the existing opening.
It was smaller than Thomas expected.
Smooth metallic shell.
Transparent polymer coating.
Serial number:
NL B9 204.
The surrounding tissue was infected.
Cultures were taken.
The wound was cleaned and treated.
Leo woke groggy but stable.
Jennifer cried when she saw him.
Not because the device looked frightening.
Because something so small had controlled three months of his life.
The capsule went into evidence after clinical documentation.
A hospital biomedical engineer examined photographs and dimensions.
“It resembles NerveLine’s adult prototype.”
“Public prototype?”
“Conference images. Not identical.”
“What is it supposed to measure?”
“Interstitial biomarkers.”
“Stress?”
“Potentially cortisol metabolites, inflammatory markers, temperature.”
“In the cheek?”
The engineer shook his head.
“The adult prototype was tested in upper arm tissue.”
Why Leo’s cheek?
More blood flow?
Less visible under clothing?
Or because Greg wanted it hidden?
NerveLine BioSystems finally responded to investigators.
Their attorney said the company had no authorized pediatric implant program.
Then Detective Bell showed them the serial number.
The response changed.
They asked for twenty four hours.
That alone told everyone the device was theirs.
Leo’s infection responded to IV antibiotics.
The strange smell faded.
Thomas explained to Jennifer that the sweet odor had likely come from infected drainage mixed with the polymer material and local contamination, not anything mysterious.
One frightening clue became ordinary medicine.
Good.
The story did not need everything to be sinister.
Then Leo’s blood work showed mild dehydration and iron deficiency.
Not starvation.
Not poisoning.
But his weight had dropped six pounds in three months.
Jennifer had noticed.
Greg said growth spurts made children strange.
She believed him.
Leo told the hospital social worker that Greg controlled food before scan nights.
“Why?”
“He says food changes numbers.”
“What numbers?”
Leo did not know.
On some evenings Greg allowed dinner normally.
On others, he made Leo wait.
Sometimes he told him to run around the backyard.
Sometimes to sit in darkness.
Sometimes he shouted until Leo cried.
Then scanned the cheek.
The program was not simply passive observation.
Someone wanted controlled conditions.
Did Northshore instruct Greg?
That became the question.
Greg’s phone was preserved under warrant after investigators developed sufficient evidence related to the suspected unauthorized procedure and child abuse.
Messages appeared between Greg and a Northshore employee.
Name:
Kara Pike.
Research operations coordinator.
Kara:
Need one fasting baseline tonight.
Greg:
He complains.
Kara:
Water okay. No calories four hours.
Greg:
He gets dramatic.
Kara:
Document behavior. Do not force.
That language mattered.
Do not force.
Greg had.
Another:
Kara:
Need challenge reading before bed.
Greg:
What counts?
Kara:
Normal household stress. Homework disagreement, screen limit, etc. Nothing artificial.
Greg:
Got it.
Later that night Greg messaged:
Red reading after yelling. Best one yet.
Kara replied:
Do not deliberately provoke.
Greg:
Relax.
So Northshore had not explicitly instructed abuse in those messages.
But they knew something was wrong.
Kara continued accepting data.
The program did not stop.
Why?
The ninety day dataset mattered.
Another message:
Kara:
N09 cannot miss final week. Investor demo uses pediatric longitudinal graph.
Pediatric.
So the company knew the subject was a child.
Publicly, they denied pediatric implants.
Internally, they referred to pediatric longitudinal data.
The contradiction deepened.
Then financial records arrived.
Greg received:
5,000 dollars initial participation.
500 monthly compliance stipend.
Final completion bonus:
25,000 dollars.
Not ten thousand.
The consent shown to Jennifer listed ten.
Greg had a separate contractor agreement.
Total potential compensation:
31,500 dollars.
He had already borrowed against the completion bonus through a payroll advance service.
If Leo failed to complete Day 90, Greg might owe part back.
That explained urgency.
But another clause mattered more.
Confidential research participation violation:
Liquidated damages up to 75,000 dollars for unauthorized disclosure of proprietary device data.
If Greg brought Leo to an outside hospital and the implant became public, he feared financial ruin.
He was not protecting Leo.
He was protecting the contract he had signed.
Then Bell found one voice memo on Greg’s phone.
Kara Pike speaking.
“If swelling gets worse, use the designated clinic. Do not take N09 to an outside ER unless there is a true emergency. They will image it.”
Thomas stopped the recording.
Leo had a fever over 101 and a facial infection.
Greg still wanted antibiotics and departure.
The company’s instruction may not have said ignore emergencies.
Greg had chosen secrecy over medical judgment.
Then the final part of Kara’s message played.
May you like
“If anyone outside the program finds the capsule, call me before you explain anything.”
Continue to the next part: Northshore’s own research coordinator expected employees to keep the implant hidden from outside doctors.
